Article: HydroCision, Inc. Elects Peter Feinstein and Art Rosenthal to Board of Directors.

BILLERICA, Mass. -- HydroCision, Inc. (www.hydrocision.com) announced today that it has elected two new members to its board of directors - Peter Feinstein and Art Rosenthal. Ph.D. The two new members were added to the company's board to provide in-depth industry knowledge and technical expertise.

Mr. Feinstein has been actively involved in the medical industry since 1981. He is currently a Partner, Managing Director and founder of BioVentures Investors LLC, a venture fund investing in the healthcare sector. He was previously the founder, Chairman and CEO of Feinstein Kean Healthcare in Cambridge, MA, a leading investor relations, marketing and strategic ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!